Comments
Loading...

Spero Therapeutics

SPRONASDAQ
Logo brought to you by Benzinga Data
$0.9551
-0.04-4.30%
At close: -
$0.9551
0.000.00%
After Hours: Dec 20, 5:09 PM EDT

Spero Therapeutics (NASDAQ:SPRO) Stock, Earnings Estimates, EPS, And Revenue

Spero Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 12
EPS Estimate
$-0.520
Quarterly Revenue Estimate
$3.4M
Annual Revenue
(as of Sep 30)
$89.9M

Analyze the earnings history of Spero Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Spero Therapeutics (SPRO) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-14$-0.32$-0.3611.1 %
Jun 20242024-08-05$-0.33$-0.3813.2 %
Mar 20242024-05-15$-0.24$-0.04-500.0 %
Dec 20232024-03-13$0.96$-0.101060.0 %

Spero Therapeutics (SPRO) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-11-14$13.47M$7.67M75.6 %
Jun 20242024-08-05$10.20M$3.27M211.8 %
Mar 20242024-05-15$9.27M$21.53M-57.0 %
Dec 20232024-03-13$73.52M$18.63M294.6 %

FAQ

Q

When is Spero Therapeutics (NASDAQ:SPRO) reporting earnings?

A

Spero Therapeutics (SPRO) is scheduled to report earnings on March 12, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Spero Therapeutics (NASDAQ:SPRO)?

A

The Actual EPS was $-0.32, which beat the estimate of $-0.36.

Q

What were Spero Therapeutics’s (NASDAQ:SPRO) revenues?

A

The Actual Revenue was $13.5M, which beat the estimate of $7.7M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch